4.7 Letter

High frequency of low-count monoclonal B-cell lymphocytosis in hospitalized COVID-19 patients

Related references

Note: Only part of the references are listed.
Article Hematology

COVID-19 vaccine failure in chronic lymphocytic leukaemia and monoclonal B-lymphocytosis; humoural and cellular immunity

Yandong Shen et al.

Summary: Chronic lymphocytic leukaemia (CLL) and monoclonal B-cell lymphocytosis (MBL) patients have poor immune response to COVID-19 vaccines, with most of them failing to produce sufficient antibody levels. The patients' treatment status and reduced immune function are associated with vaccine immunization failure.

BRITISH JOURNAL OF HAEMATOLOGY (2022)

Article Hematology

Progression and survival of MBL: a screening study of 10 139 individuals

Susan L. Slager et al.

Summary: Monoclonal B-cell lymphocytosis (MBL) is a common hematological premalignant condition that is associated with a fourfold increased risk of lymphoid malignancies in individuals with low-count MBL (LC-MBL).

BLOOD (2022)

Article Oncology

COVID-19 severity and mortality in patients with CLL: an update of the international ERIC and Campus CLL study

Thomas Chatzikonstantinou et al.

Summary: Patients with CLL are more susceptible to the impact of COVID-19, with age, CLL-directed treatment, and cardiac failure being significant risk factors for outcomes. Untreated patients have a better chance of survival, and age, cardiac failure, and CLL-directed treatment are significant risk factors for OS.

LEUKEMIA (2021)

Review Respiratory System

The immune response to SARS-CoV-2 and COVID-19 immunopathology -- Current perspectives

J. L. Boechat et al.

Summary: SARS-CoV-2 is a new beta coronavirus responsible for COVID-19, declared a pandemic by the World Health Organization. Control of the pandemic has been hindered by limited knowledge of the virus-host interactions. The rapid clinical course of COVID-19 is linked to innate immune response in asymptomatic or mild cases.

PULMONOLOGY (2021)

Article Immunology

The Immunological Factors Predisposing to Severe Covid-19 Are Already Present in Healthy Elderly and Men

Gizem Kilic et al.

Summary: This study found that the immune characteristics associated with severe COVID-19 in males and the elderly are present in healthy individuals of the same demographic groups.

FRONTIERS IN IMMUNOLOGY (2021)

Article Medicine, General & Internal

Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China

Dawei Wang et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)

Article Allergy

Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan

Xiaochen Li et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2020)

Article Cell Biology

Systems-Level Immunomonitoring from Acute to Recovery Phase of Severe COVID-19

Lucie Rodriguez et al.

CELL REPORTS MEDICINE (2020)

Article Medical Laboratory Technology

Non-CLL-like Monoclonal B-Cell Lymphocytosis in the General Population: Prevalence and Phenotypic/Genetic Characteristics

Wendy G. Nieto et al.

CYTOMETRY PART B-CLINICAL CYTOMETRY (2010)

Article Medicine, General & Internal

Monoclonal B-cell lymphocytosis and chronic lymphocytic leukemia

Andy C. Rawstron et al.

NEW ENGLAND JOURNAL OF MEDICINE (2008)

Review Hematology

Diagnostic criteria for monoclonal B-cell lymphocytosis

GE Marti et al.

BRITISH JOURNAL OF HAEMATOLOGY (2005)